Skip to content

Income Tax at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$561M+10.2%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$221.5M+163%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$1.5M
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$120K-408%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$347K-99.5%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's income tax?
Disc Medicine (IRON) reported income tax of $51K in Q1 2026.
How has Disc Medicine's income tax changed year-over-year?
Disc Medicine's income tax decreased by 57.1% year-over-year, from $119K to $51K.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.